The evolving landscape of protein kinases in breast cancer: clinical implications.
about
Activation of the PI3K/mTOR/AKT pathway and survival in solid tumors: systematic review and meta-analysisP53- and mevalonate pathway-driven malignancies require Arf6 for metastasis and drug resistance.Targeting ADAM-17 with an inhibitory monoclonal antibody has antitumour effects in triple-negative breast cancer cells.Phospho-kinase profile of colorectal tumors guides in the selection of multi-kinase inhibitors.Identification of therapeutic targets in ovarian cancer through active tyrosine kinase profiling.Biological insights into effective and antagonistic combinations of targeted agents with chemotherapy in solid tumors.Novel application of the published kinase inhibitor set to identify therapeutic targets and pathways in triple negative breast cancer subtypes.mTOR pathway protein immunoexpression as a prognostic factor for survival in head and neck cancer patients: a systematic review and meta-analysis.Efficacy of neratinib in the treatment of HER2/neu-amplified epithelial ovarian carcinoma in vitro and in vivo.Transcriptomic analyses identify association between mitotic kinases, PDZ-binding kinase and BUB1, and clinical outcome in breast cancer.Translation in solid cancer: are size-based response criteria an anachronism?Short hairpin RNA-mediated gene silencing of ADAM17 inhibits the growth of breast cancer MCF‑7 cells in vitro and in vivo and its mechanism of action.
P2860
Q26830671-6362F5A8-CDA6-4468-9B23-089946EAC7E6Q27308938-BE50D417-93A4-4414-A2B2-2B3A5BB5C057Q36086816-F35719FD-C64F-4765-A400-795E1248F95FQ36544553-54B7D26C-1D97-4343-9093-2BC54EEB09ADQ36557500-DD4812E4-9C02-4CA6-B832-2E18D727C215Q38171330-0751802B-F331-4700-A708-C3C289D2C79BQ38647605-4C45640D-DC22-4A87-8FA3-DF510081E25BQ38667738-70EB65A6-0718-4F01-BC3F-920A4E28BC14Q38708134-4B0FB47F-EE82-473B-A1D4-724E3FA99D77Q42489330-92725EF4-7D51-4D9C-951B-EE61882B722FQ47445819-3008C384-996F-47E8-A13A-8D27BE191686Q49378719-C5F6D302-A94C-444D-B199-F9A995DA81FB
P2860
The evolving landscape of protein kinases in breast cancer: clinical implications.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The evolving landscape of protein kinases in breast cancer: clinical implications.
@en
type
label
The evolving landscape of protein kinases in breast cancer: clinical implications.
@en
prefLabel
The evolving landscape of protein kinases in breast cancer: clinical implications.
@en
P50
P1476
The evolving landscape of protein kinases in breast cancer: clinical implications
@en
P2093
Atanasio Pandiella
Bostjan Seruga
P356
10.1016/J.CTRV.2012.05.004
P577
2012-06-15T00:00:00Z